SEC EDGAR filings, ownership reports, and insider transactions for PMV Pharmaceuticals, Inc..
Recent SEC filings for PMV Pharmaceuticals, Inc. including 10-Q, 8-K, SCHEDULE 13G/A and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 12 Nov 2025 | 30 Sep 2025 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Nov 2025 | 12 Nov 2025 | 001-39539 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 12 Nov 2025 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | 29 Oct 2025 | 27 Oct 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 27 Oct 2025 | 23 Oct 2025 | ||
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 27 Oct 2025 | 005-91714 | ||
| 144 | Open 144 document | View SEC filing for 144 | 23 Oct 2025 | 001-39539 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 23 Sep 2025 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | 12 Sep 2025 | 10 Sep 2025 | ||
| 144 | Open 144 document | View SEC filing for 144 | 10 Sep 2025 | 001-39539 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 Sep 2025 | 10 Sep 2025 | 001-39539 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 14 Aug 2025 | 005-91714 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 13 Aug 2025 | 005-91714 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 07 Aug 2025 | 30 Jun 2025 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 07 Aug 2025 | 07 Aug 2025 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | 03 Jul 2025 | 01 Jul 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Jul 2025 | 01 Jul 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Jul 2025 | 01 Jul 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Jul 2025 | 01 Jul 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Jun 2025 | 05 Jun 2025 | 001-39539 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 15 May 2025 | 005-91714 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 May 2025 | 31 Mar 2025 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 May 2025 | 09 May 2025 | 001-39539 |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 25 Apr 2025 | 31 Dec 2024 | 001-39539 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 25 Apr 2025 | 001-39539 | |
| DEF 14A | Open DEF 14A document | Open XBRL data | View SEC filing for DEF 14A | DEF 14A | 25 Apr 2025 | 05 Jun 2025 | 001-39539 |
| 3 | Open 3 document | View SEC filing for 3 | 23 Apr 2025 | 21 Apr 2025 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 08 Apr 2025 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | 05 Mar 2025 | 03 Mar 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 05 Mar 2025 | 03 Mar 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 05 Mar 2025 | 03 Mar 2025 | ||
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 03 Mar 2025 | 31 Dec 2024 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 03 Mar 2025 | 03 Mar 2025 | 001-39539 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 21 Feb 2025 | 005-91714 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 14 Feb 2025 | 005-91714 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 14 Feb 2025 | 005-91714 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 10 Feb 2025 | 005-91714 | ||
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 28 Jan 2025 | 333-284560 | |
| 4 | Open 4 document | View SEC filing for 4 | 22 Jan 2025 | 03 Dec 2024 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 12 Dec 2024 | 005-91714 | ||
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 27 Nov 2024 | 333-283349 | ||
| 424B3 | Open 424B3 document | View SEC filing for 424B3 | 424B3 | 27 Nov 2024 | 333-283349 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 25 Nov 2024 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 25 Nov 2024 | 333-283349 | ||
| S-3 | Open S-3 document | View SEC filing for S-3 | S-3 | 20 Nov 2024 | 333-283349 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Nov 2024 | 005-91714 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 07 Nov 2024 | 30 Sep 2024 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 07 Nov 2024 | 07 Nov 2024 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | 03 Oct 2024 | 13 Aug 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Oct 2024 | 13 Aug 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Oct 2024 | 13 Aug 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 12 Sep 2024 | 11 Sep 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 12 Sep 2024 | 11 Sep 2024 | ||
| SC TO-I/A | Open SC TO-I/A document | View SEC filing for SC TO-I/A | SC TO-I/A | 14 Aug 2024 | 005-91714 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 08 Aug 2024 | 30 Jun 2024 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 Aug 2024 | 05 Aug 2024 | 001-39539 |
| SC TO-I | Open SC TO-I document | View SEC filing for SC TO-I | SC TO-I | 16 Jul 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 08 Jul 2024 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 07 Jun 2024 | 06 Jun 2024 | 001-39539 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 May 2024 | 31 Mar 2024 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 May 2024 | 09 May 2024 | 001-39539 |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 24 Apr 2024 | 31 Dec 2023 | 001-39539 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 24 Apr 2024 | 001-39539 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 24 Apr 2024 | 06 Jun 2024 | 001-39539 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | FILING PMV PHARMACEUTICALS, INC. | 09 Apr 2024 | 005-91714 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 29 Feb 2024 | 31 Dec 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 29 Feb 2024 | 29 Feb 2024 | 001-39539 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2024 | 005-91714 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 14 Feb 2024 | 005-91714 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 14 Feb 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 14 Feb 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 13 Feb 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 29 Jan 2024 | 005-91714 | ||
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 24 Jan 2024 | 333-276667 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | FILING PMV PHARMACEUTICALS, INC. | 23 Jan 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 23 Jan 2024 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jan 2024 | 18 Jan 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jan 2024 | 18 Jan 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jan 2024 | 18 Jan 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 18 Jan 2024 | 18 Jan 2024 | 001-39539 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 11 Jan 2024 | 05 Jan 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 05 Jan 2024 | 04 Jan 2024 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | 24 Nov 2023 | 22 Nov 2023 | ||
| 144 | Open 144 document | View SEC filing for 144 | 22 Nov 2023 | 001-39539 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Nov 2023 | 18 Oct 2023 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 Nov 2023 | 30 Sep 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Nov 2023 | 09 Nov 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Oct 2023 | 12 Oct 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 11 Oct 2023 | 11 Oct 2023 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Sep 2023 | 15 Sep 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Sep 2023 | 15 Sep 2023 | |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 2 | 23 Aug 2023 | 005-91714 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 Aug 2023 | 30 Jun 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Aug 2023 | 09 Aug 2023 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2023 | 07 Aug 2023 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 07 Jul 2023 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Jun 2023 | 08 Jun 2023 | 001-39539 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 19 May 2023 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 May 2023 | 12 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 May 2023 | 12 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 May 2023 | 12 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 May 2023 | 12 May 2023 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 10 May 2023 | 005-91714 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 10 May 2023 | 31 Mar 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 May 2023 | 10 May 2023 | 001-39539 |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 28 Apr 2023 | 333-260012 | ||
| ARS | Open ARS document | View SEC filing for ARS | ARS | 28 Apr 2023 | 31 Dec 2022 | 001-39539 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 28 Apr 2023 | 001-39539 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 28 Apr 2023 | 24 Apr 2023 | 001-39539 |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF14A | 28 Apr 2023 | 08 Jun 2023 | 001-39539 |
| POS AM | Open POS AM document | View SEC filing for POS AM | POS AM | 01 Mar 2023 | 333-260012 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 01 Mar 2023 | 31 Dec 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 01 Mar 2023 | 01 Mar 2023 | 001-39539 |
| POSASR | Open POSASR document | View SEC filing for POSASR | POSASR | 01 Mar 2023 | 333-260012 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2023 | 005-91714 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 14 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 14 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 10 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 10 Feb 2023 | 005-91714 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 09 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 31 Jan 2023 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 30 Jan 2023 | 25 Nov 2022 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | FILING PMV PHARMACEUTICALS, INC. | 25 Jan 2023 | 005-91714 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 25 Jan 2023 | 333-269394 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | COWEN FINANCIAL PRODUCTS LLC | 24 Jan 2023 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Nov 2022 | 04 Nov 2022 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 08 Nov 2022 | 03 Nov 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 08 Nov 2022 | 30 Sep 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 Nov 2022 | 08 Nov 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 04 Nov 2022 | 03 Nov 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Sep 2022 | 09 Sep 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Sep 2022 | 09 Sep 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 Aug 2022 | 30 Jun 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Aug 2022 | 09 Aug 2022 | 001-39539 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 11 Jul 2022 | 005-91714 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | FILING PMV PHARMACEUTICALS, INC. | 07 Jul 2022 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | PMV PHARMACEUTICALS, INC. | 17 Jun 2022 | 005-91714 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 Jun 2022 | 07 Jun 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 06 Jun 2022 | 02 Jun 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | 31 May 2022 | 26 May 2022 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 26 May 2022 | 26 May 2022 | 001-39539 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 10 May 2022 | 31 Mar 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 May 2022 | 10 May 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Apr 2022 | 27 Apr 2022 | |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 22 Apr 2022 | 001-39539 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 22 Apr 2022 | 02 Jun 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 Apr 2022 | 20 Apr 2022 | |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 1 | 01 Apr 2022 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | 31 Mar 2022 | 29 Mar 2022 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Mar 2022 | 08 Mar 2022 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 01 Mar 2022 | 31 Dec 2021 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 01 Mar 2022 | 01 Mar 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Feb 2022 | 10 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Feb 2022 | 10 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Feb 2022 | 10 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Feb 2022 | 10 Feb 2022 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | PMV PHARMACEUTICALS, INC. | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 11 Feb 2022 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SCHEDULE 13G | 10 Feb 2022 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Feb 2022 | 30 Dec 2021 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 04 Feb 2022 | 005-91714 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | FILING PMV PHARMACEUTICALS, INC. | 26 Jan 2022 | 005-91714 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 24 Jan 2022 | 333-262308 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | COWEN FINANCIAL PRODUCTS LLC | 19 Jan 2022 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jan 2022 | 06 Jan 2022 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 10 Jan 2022 | 05 Jan 2022 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 06 Jan 2022 | 05 Jan 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Dec 2021 | 15 Dec 2021 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 12 Nov 2021 | 30 Sep 2021 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Nov 2021 | 12 Nov 2021 | 001-39539 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 18 Oct 2021 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Oct 2021 | 06 Oct 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 05 Oct 2021 | 04 Oct 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Oct 2021 | 30 Sep 2021 | |
| S-3ASR | Open S-3ASR document | View SEC filing for S-3ASR | S-3ASR | 04 Oct 2021 | 333-260012 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2021 | 27 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 Sep 2021 | 22 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Sep 2021 | 22 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 Sep 2021 | 17 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Sep 2021 | 09 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Sep 2021 | 09 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Sep 2021 | 07 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Sep 2021 | 31 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 30 Aug 2021 | 26 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 25 Aug 2021 | 23 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 Aug 2021 | 23 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Aug 2021 | 18 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Aug 2021 | 19 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Aug 2021 | 19 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Aug 2021 | 17 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 17 Aug 2021 | 13 Aug 2021 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 13 Aug 2021 | 30 Jun 2021 | 001-39539 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 13 Aug 2021 | 13 Aug 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Aug 2021 | 10 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Aug 2021 | 09 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Aug 2021 | 05 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Aug 2021 | 02 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Aug 2021 | 03 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 30 Jul 2021 | 28 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 Jul 2021 | 23 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Jul 2021 | 21 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Jul 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jul 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jul 2021 | 20 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Jul 2021 | 13 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jul 2021 | 08 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jul 2021 | 07 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Jun 2021 | 28 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jun 2021 | 21 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 15 Jun 2021 | 11 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 11 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 09 Jun 2021 | 07 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2021 | 04 Jun 2021 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 07 Jun 2021 | 02 Jun 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Jun 2021 | 03 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Jun 2021 | 28 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Jun 2021 | 01 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 May 2021 | 25 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 May 2021 | 20 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 May 2021 | 20 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 May 2021 | 20 May 2021 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | FORM S-8 | 21 May 2021 | 333-256346 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 14 May 2021 | 31 Mar 2021 | 001-39539 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 14 May 2021 | 14 May 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 May 2021 | 10 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 May 2021 | 10 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 May 2021 | 07 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 May 2021 | 05 May 2021 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 07 May 2021 | 005-91714 | |
| 3 | Open 3 document | View SEC filing for 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 07 May 2021 | 28 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 May 2021 | 03 May 2021 | |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 23 Apr 2021 | 001-39539 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 23 Apr 2021 | 02 Jun 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Apr 2021 | 09 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Apr 2021 | 06 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Apr 2021 | 07 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Apr 2021 | 05 Apr 2021 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 07 Apr 2021 | 01 Apr 2021 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 06 Apr 2021 | 01 Apr 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Apr 2021 | 01 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 31 Mar 2021 | 29 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 26 Mar 2021 | 24 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 25 Mar 2021 | 24 Mar 2021 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 03 Mar 2021 | 31 Dec 2020 | 001-39539 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 03 Mar 2021 | 03 Mar 2021 | 001-39539 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 16 Feb 2021 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | AMENDMENT NO. 1 | 16 Feb 2021 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 12 Feb 2021 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | PMV PHARMACEUTICALS, INC. | 12 Feb 2021 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 12 Feb 2021 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 31 Dec 2020 | 08 Dec 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Nov 2020 | 18 Nov 2020 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 13 Nov 2020 | 30 Sep 2020 | 001-39539 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 13 Nov 2020 | 13 Nov 2020 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Nov 2020 | 11 Nov 2020 | |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SCHEDULE 13D | 05 Oct 2020 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 05 Oct 2020 | 005-91714 | |
| 4/A | Open 4/A document | View SEC filing for 4/A | FORM 4/A SUBMISSION | 02 Oct 2020 | 25 Sep 2020 | |
| 4/A | Open 4/A document | View SEC filing for 4/A | FORM 4/A SUBMISSION | 02 Oct 2020 | 25 Sep 2020 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 30 Sep 2020 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 29 Sep 2020 | 24 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | OWNERSHIP DOCUMENT | 29 Sep 2020 | 29 Sep 2020 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 29 Sep 2020 | 29 Sep 2020 | 001-39539 |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 28 Sep 2020 | 333-249094 | |
| 424B4 | Open 424B4 document | View SEC filing for 424B4 | 424B4 | 25 Sep 2020 | 333-248627 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 24 Sep 2020 | 333-248627 | ||
| 3 | Open 3 document | View SEC filing for 3 | OWNERSHIP DOCUMENT | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| CERT | Open CERT document | View SEC filing for CERT | 24 Sep 2020 | 001-39539 | ||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | S-1/A | 24 Sep 2020 | 333-248627 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 22 Sep 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 22 Sep 2020 | |||
| 8-A12B | Open 8-A12B document | View SEC filing for 8-A12B | 8-A12B | 21 Sep 2020 | 001-39539 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 21 Sep 2020 | |||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | S-1/A | 21 Sep 2020 | 333-248627 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 17 Sep 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 11 Sep 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 04 Sep 2020 | |||
| S-1 | Open S-1 document | View SEC filing for S-1 | S-1 | 04 Sep 2020 | 333-248627 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 18 Aug 2020 | |||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 03 Aug 2020 | 377-03247 | ||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 31 Jul 2020 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 23 Jul 2020 | |||
| DRS | Open DRS document | View SEC filing for DRS | 26 Jun 2020 | 377-03247 | ||
| D | Open D document | View SEC filing for D | 02 Mar 2017 | 021-281658 |
PMV Pharmaceuticals, Inc. files with the SEC under CIK 0001699382. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.